Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0848332 (
Spots
)
453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Bacillus subtilis mutant cal1 carries a non-reverting mutation in ribosomal protein L17 (r-protein L17) that causes both resistance to the antibiotic chalcomycin (Calr) and temperature-sensitive sporulation (
Spots
). Second-site suppressor (rev) mutations that relieve the
Spots
phenotype have been isolated from cal1. Three suppressor mutations - rev4, rev10, rev11 - each increase the sporulation frequency of cal1 at the non-permissive temperature from 3% to 95% of the wild-type level. The cal1 rev strains remain resistant to chalcomycin and two-dimensional gel electrophoresis analysis indicates that they contain the same altered r-protein L17 as the original cal1 strain and no additional altered r-proteins. The three rev mutations have been mapped at a single locus between narA and sacA on the B. subtilis chromosome and recombination indexes for the rev mutations indicate that they are tightly linked to one another. Antibiotic resistance
Spots
mutations that cause temperature-sensitive sporulation have previously been isolated in RNA polymerase, in the 30S and 50S subunits of the ribosome, and in
elongation factor G
. The rev4, 10, and 11 suppressor mutations are non-specific in their action in that they restore significant levels of sporulation at the non-permissive temperature in all of the
Spots
strains that we have tested. This result suggests that
Spots
mutations in components of the B. subtilis transcription and translation systems share a common molecular basis for their sporulation-defective phenotypes.
...
PMID:Intergenic suppressors of temperature-sensitive sporulation in Bacillus subtilis are allele non-specific. 680 27
The temperature-sensitive sporulation phenotype (
Spots
) of Bacillus subtilis RNA polymerase, ribosomal and protein synthesis
elongation factor G
mutations can be corrected by supplementing the growth medium with carbohydrates such as ribose or glycerol, or with synthetic lipids such as Tween 40. The data suggest that these mutations affect a single common aspect of developmental cell function. It is proposed that these lesions prevent sporulation by disturbing the regulation of sporulating cell metabolic balance.
...
PMID:Physiological suppression of Bacillus subtilis conditioned sporulation phenotypes: RNA polymerase and ribosomal mutations. 680 30